The coordinated functional expression of epidermal growth factor receptor and c-Met in colorectal carcinoma metastasis

In Vivo

Volumn 14, Issue 5, 2000, Pages 587-596

  Herynk, Matthew H ^a   Radinsky, Robert ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

c Met; Colorectal carcinoma; Epidermal growth factor receptor; Liver; Organ specific metastasis; Catenin

Indexed keywords

4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; ACTIN; BETA CATENIN; CETUXIMAB; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOTOXIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; FOCAL ADHESION KINASE; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; JANUS KINASE 2; LIGAND; LIPOCORTIN 1; NERVE GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN CRK; PROTEIN CRK II; PROTEIN GAB 1; PROTEIN GAP; PROTEIN KINASE C; PROTEIN NCK; PROTEIN SHC; PROTEIN TYROSINE KINASE; SCATTER FACTOR RECEPTOR; SOMATOMEDIN RECEPTOR; STAT5 PROTEIN; TRANSCRIPTION FACTOR; TUMOR MARKER; UNCLASSIFIED DRUG; UNINDEXED DRUG; VAV PROTEIN;

ADVANCED CANCER; CANCER GROWTH; CANCER INVASION; CANCER RADIOTHERAPY; CELL INTERACTION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL CARCINOMA; CYTOSTASIS; ENZYME ACTIVATION; ENZYME REGULATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; METASTASIS; MICROENVIRONMENT; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; TUMOR; TUMOR CELL;

EID: 0034579401     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (112)

1. Growth factors and their receptors in metastasis
2. Influence of the host microenvironment on the clonal selection of human colon carcinoma cells during primary tumor growth and metastasis
3. Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes memorial award lecture
4. 'Seed and soil' revisited: Mechanisms of site-specific metastasis
5. Cancer metastasis: Tumor cell and host organ properties important in metastasis to specific secondary sites
6. The distribution of secondary growths in cancer of the breast
7. Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts
8. Patterns of metastasis in human malignancies
9. Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue
10. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells
11. Tissue-specific transformation by oncogenic mutants of epidermal growth factor receptor
12. Hepatocyte growth factor and its receptor, the tyrosine kinase encoded by the c-MET protooncogene
13. Mechanism of met oncogene activation
14. Frequency of TPR-MET rearrangement in patients with gastric carcinoma and in first-degree relatives
15. Germline and somatic mutations in the tyrosine kinase domain of the MET protooncogene in papillary renal carcinomas
16. Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene
17. Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas
18. Activating mutations for the met tyrosine kinase receptor in human cancer
19. Expression of constitutively activated hepatocyte growth factor/scatter factor receptor (c-met) in B16 melanoma cells selected for enhanced liver colonization
20. Cellular adherence elicits ligand-independent activation of the Met cell-surface receptor
21. Constitutive activation of c-Met in liver metastatic B16 melanoma cells depends on both substrate adhesion and cell density and is regulated by a cytosolic tyrosine phosphatase activity
22. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma
23. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation
24. Co-expression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer
25. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit
26. Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis
27. Co-expression of hepatocyte growth factor and its receptor in human prostate cancer
28. Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas
29. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma
30. Defective posttranslational processing activates the tyrosine kinase encoded by the MET proto-oncogene (hepatocyte growth factor receptor)
31. Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells
32. Modifications of the hepatocyte growth factor/c-met pathway by constitutive expression of transforming growth factor-alpha in rat liver epithelial cells
33. Liver regeneration
34. Monoclonal antibodies directed against the EGF receptor show differential binding of amphiregulin and EGF to the EGF receptor
35. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4
36. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization
37. Scatter factor/hepatocyte growth factor is essential for liver development
38. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud
39. Liver regeneration 7. Prometheus' myth revisited: Transgenic mice as a powerful tool to study liver regeneration
40. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family
41. The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions
42. Preferential activation of the epidermal growth factor receptor in human colon carcinoma liver metastases in nude mice
43. Regulation of tumor cell growth at organ-specific metastases
44. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice
45. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice
46. Inhibition of epidermal growth factor receptor kinase induces protease-dependent apoptosis in human colon cancer cells
47. Inhibition of human colon cancer malignant cell behavior and growth by antisense epidermal growth factor receptor expression vector
48. Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives
49. Synergistic growth inhibition and induction of apoptosis by a novel mixed backbone antisense oligonucleotide targeting CRIPTO in combination with C225 anti-EGFR monoclonal antibody and 8-Cl-cAMP in human GEO colon cancer cells
50. Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A
51. Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225
52. Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay
53. Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer
54. Hepatocyte growth factor and its receptor/c-Met regulate both cell growth and invasion of human pancreatic cancer
55. Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene
56. Liver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: Its specific receptor c-met does
57. Hepatocyte growth factor and c-Met/hepatocyte growth factor receptor in pulmonary adenocarcinomas: An evaluation of their expression as prognostic markers
58. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression
59. E-cadherin mediated adhesion system in cancer cells
60. Structural basis of calcium-induced E-cadherin rigidification and dimerization
61. Structural basis of cell-cell adhesion by cadherins
62. Dysregulated expression of beta-catenin marks early neoplastic change in Apc mutant mice, but not all lesions arising in Msh2 deficient mice
63. Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells
64. The alphaE-catenin gene (CTNNA1) acts as an invasion-suppressor gene in human colon cancer cells
65. Dysregulation of the E-cadherin/catenin complex by irreversible mutations in human carcinomas
66. A mutation in alpha-catenin disrupts adhesion in clone A cells without perturbing its actin and beta-catenin binding activity
67. Mutation of alpha-catenin results in invasiveness of human HCT-8 colon cancer cells
68. Negative regulation of Wingless signaling by D-axin, a Drosophila homolog of axin
69. Down-regulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta
70. Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor
71. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma
72. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC
73. Association of the APC gene product with beta-catenin
74. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly
75. Beta-catenin associates with the actin-bundling protein fascin in a noncadherin complex
76. Armadillo is required for adherens junction assembly, cell polarity, and morphogenesis during Drosophila embryogenesis
77. Tyrosine phosphorylation and cadherin/catenin function
78. Molecular analysis of the armadillo locus: Uniformly distributed transcripts and a protein with novel internal repeats are associated with a Drosophila segment polarity gene
79. Effect of epidermal growth factor on cadherin-mediated adhesion in a human oesophageal cancer cell line
80. Hepatocyte growth factor alters the polarity of Madin-Darby canine kidney cell monolayers
81. Tyrosine phosphorylation of beta-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells
82. Aberrant expression and phosphorylation of beta-catenin in human colorectal cancer
83. Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor
84. Epidermal growth factor-dependent dissociation of CrkII proto-oncogene product from the epidermal growth factor receptor in human glioma cells
85. Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze Crk-phosphotyrosine-dependent interactions in vitro
86. Analysis of receptor signaling pathways by mass spectrometry: Identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors
87. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav
88. Association of signaling proteins with a nonmitogenic heterodimeric complex composed of epidermal growth factor receptor and kinase-inactive p185c-neu
89. A 66-kDa protein associated with epidermal growth factor receptor is a proteolytic fragment of phosphoinositide-specific phospholipase C
90. Identification of tyrosine phosphorylation sites in human Gab-1 protein by EGF receptor kinase in vitro
91. The tyrosine phosphorylated carboxyterminus of the EGF receptor is a binding site for GAP and PLC-gamma
92. Induction of tyrosine phosphorylation and association of beta-catenin with EGF receptor upon tryptic digestion of quiescent cells at confluence
93. The EGF receptor is an actin-binding protein
94. STAT 1alpha/1beta, STAT 3 and STAT 5: Expression and association with c-MET and EGF-receptor in long-term cultures of human hepatocytes
95. Protein tyrosine phosphatase 1B interacts with and is tyrosine phosphorylated by the epidermal growth factor receptor
96. Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone
97. Mechanism of biological synergy between cellular Src and epidermal growth factor receptor
98. c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function
99. Mitogenic signaling from the egf receptor is attenuated by a phospholipase C-gamma/protein kinase C feedback mechanism
100. Interactions between the epidermal growth factor receptor and type I protein kinase A: Biological significance and therapeutic implications
101. Protein kinase-c activation inhibits tyrosine phosphorylation of the c- met protein
102. Specific uncoupling of GRB2 from the Met receptor. Differential effects on transformation and motility
103. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death
104. Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis
105. The motility signal of scatter factor/hepatocyte growth factor mediated through the receptor tyrosine kinase met requires intracellular action of Ras
106. An 11-amino acid sequence from c-met initiates epithelial chemotaxis via phosphatidylinositol 3-kinase and phospholipase C
107. The hepatocyte growth factor receptor kinase-mediated phosphorylation of lipocortin-1 transduces the proliferating signal of the hepatocyte growth factor
108. Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms
109. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice